Health

Washington, D.C. – Energy and Commerce Committee Republican Leader Greg Walden (R-OR) released the following statement after President Trump’s speech on the administration’s efforts to lower health care costs.

“During the pandemic, we’ve witnessed first-hand the value of American innovation, and many stakeholders have warned the Most Favored Nation rule would put American innovation and the development of new treatments and cures at risk. I worked closely with President Trump on Right to Try, and I know how much he appreciates the hope that new treatments and cures bring to...

Washington, D.C. - Energy and Commerce Committee Republican Leader Greg Walden (R-OR), Oversight and Investigations Subcommittee Republican Leader Brett Guthrie (R-KY), and Health Subcommittee Republican Leader Dr. Michael Burgess (R-TX) sent a letter to Centers for Disease Control and Prevention (CDC) Director Robert R. Redfield, M.D. to ask the CDC for complete and updated information on domestic BioSafety Level (BSL)-3 and Animal BSL (ABSL)-3 laboratory capacity with the ability to conduct preclinical animal model research for COVID-19 vaccines, therapeutics, and diagnostics development.

Ranging from BSL-1 to BSL-4, with BSL-4 posing...

Excerpt: “The lack of information on BSL-3 laboratory capacity is of concern because it may be contributing to delays and bottlenecks in preclinical COVID-19 research. Although the BSL-3 laboratory capacity is not fully known, the extraordinary demand for COVID-19 preclinical research may have overwhelmed the known, available capacity,” wrote Walden, Guthrie, and Burgess.

Click HERE to read the letter to the CDC.